Long-term efficacy and safety of raltegravir in the management of HIV infection

Raltegravir is an integrase strand-transfer inhibitor approved for the treatment of HIV infection. It was the first medication in a novel class of antiretroviral agents to be approved for use in the United States in 2007. Raltegravir exhibits potent activity against wild-type HIV-1, but resistance d...

Descripción completa

Detalles Bibliográficos
Autores principales: Liedtke, Michelle D, Tomlin, C Ryan, Lockhart, Staci M, Miller, Misty M, Rathbun, R Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965364/
https://www.ncbi.nlm.nih.gov/pubmed/24672249
http://dx.doi.org/10.2147/IDR.S40168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965364/
https://www.ncbi.nlm.nih.gov/pubmed/24672249
http://dx.doi.org/10.2147/IDR.S40168

Ejemplares similares